Philadelphia Chromosome-Like ALL Linked to Poor Outcomes in Adults | GenomeWeb https://t.co/YekulVVVm2
5:20pm November 22nd 2016 via Hootsuite
CMS 2017 Pricing Brings Good News for Several Molecular Diagnostic Firms | GenomeWeb https://t.co/09Um3iMe1Z
4:15pm November 22nd 2016 via Hootsuite
Some Zika-Caused Defects Don’t Show Up Until Well After Birth - WSJ https://t.co/qMa4Nfj8YC
3:15pm November 22nd 2016 via Hootsuite
Your Office Has a Microbiome, and It Might Make You Sick | WIRED https://t.co/3B1sgewOiE
1:58pm November 22nd 2016 via Hootsuite
Epic Sciences' Single Cell-CTC Analyses Lead to New Strategies to Predict PARP Inhibitor Response | GenomeWeb ($) https://t.co/qrLBhfUaUQ
11:15am November 22nd 2016 via Hootsuite
Copy Number Profiles Classify Lung Cancer Patients as Sensitive or Resistant to Therapy | GenomeWeb https://t.co/0ZhXm5q6n4
9:59am November 22nd 2016 via Hootsuite
This ancient Chinese bird kept its feathers, and colors, for 130 million years - The Washington Post https://t.co/kA5dTl2R32
9:09am November 22nd 2016 via Hootsuite
Cyborg 'biohacker' dad could lose custody of his kids because of it | Fusion https://t.co/HMfcre4VbL
7:19pm November 21st 2016 via Hootsuite
Quit Social Media. Your Career May Depend on It. - The New York Times https://t.co/eEGKx6UVYa
9:53am November 21st 2016 via Hootsuite
Thermo Fisher Scientific Submits Premarket Application to FDA for Universal, NGS-Based Oncology Test | Business Wire https://t.co/X3CmnTSkmU
10:22am November 18th 2016 via Hootsuite
Nigerians are falling for MMM, a Russian Ponzi scheme — Quartz https://t.co/REwu3yOGnL
7:40am November 18th 2016 via Hootsuite
Landmark report by Surgeon General calls drug crisis ‘a moral test for America’ - The Washington Post https://t.co/wOrbG2fTiB
6:24am November 18th 2016 via Hootsuite
Facebook fake-news writer: ‘I think Donald Trump is in the White House because of me’ - The Washington Post https://t.co/YJPcyL8xwX
12:30pm November 17th 2016 via Hootsuite
Theranos Whistleblower Shook the Company—And His Family - WSJ https://t.co/00sT4MD9Il
11:30am November 17th 2016 via Hootsuite
According to Snopes, Fake News Is Not the Problem | Backchannel https://t.co/hAngepUraQ
8:15am November 17th 2016 via Hootsuite
The FBI recommends you cover your laptop's webcam, for good reason | Engadget https://t.co/7ShIgekKw9
6:58am November 17th 2016 via Hootsuite
Northwestern University to Use Guardant Liquid Biopsy for Patient Testing | GenomeWeb https://t.co/SAV0fpvkzU
2:35pm November 16th 2016 via Hootsuite
Invitae Commences $40M Public Stock Offering | GenomeWeb https://t.co/rDAbDbHRQ0
1:35pm November 16th 2016 via Hootsuite
Agilent Technologies Q4 Revenues Surge 7 Percent | GenomeWeb https://t.co/1H3G44AJgJ
12:24pm November 16th 2016 via Hootsuite
CRISPR gene-editing tested in a person for the first time : Nature News https://t.co/3foxHPyKqV
10:30am November 16th 2016 via Hootsuite
Ebola Might Not Make Some People Sick, Study Finds - NBC News https://t.co/dPudV5Sg9p
9:17am November 16th 2016 via Hootsuite
It’s time to reboot bioinformatics education; 'bioinformatics is here to stay - get used to it' | Todd Harris https://t.co/QXxKJ2wPJC
9:25am November 15th 2016 via Hootsuite
Roche Previews RUO CAPP-Seq Liquid Biopsy Assays at #AMP2016, Shares Early User Data | GenomeWeb ($) https://t.co/E3MP5SC7wV
6:50pm November 14th 2016 via Hootsuite
I took a DNA test hoping for surprises, but I'm exactly who I thought I was | Samantha Gillison | The Guardian https://t.co/YSQeIuviFc
5:10pm November 14th 2016 via Hootsuite
Trump’s brief medicines update sends tongues wagging at ‘FDA reform’ promise | FierceBiotech https://t.co/yeEnJ9uLFg
4:34pm November 14th 2016 via Hootsuite
BGI Launches New Desktop Sequencer in China, Registers Larger Version With CFDA | GenomeWeb ($) https://t.co/3FJIbihUwS
11:15am November 14th 2016 via Hootsuite
Natera Sees NIPT Reimbursement Pick Up for Average Risk Pregnancies; Continues Move Into Oncology | GenomeWeb ($) https://t.co/rPwj4EoiFb
10:50am November 14th 2016 via Hootsuite
Thermo Fisher Targets Cancer Immunotherapy Prediction With New Oncomine Research Panel #AMP2016 | GenomeWeb ($) https://t.co/5EeHAwjNB2
9:50am November 14th 2016 via Hootsuite
Rady Children's Institute for Genomic Medicine Prepares to Expand Clinical Genome Sequencing | GenomeWeb ($) https://t.co/8Gx9gY5X9J
8:33am November 14th 2016 via Hootsuite
Why Some Flus Are Deadliest in Young Adults: The first flu you get matters for the rest of your life | The Atlantic https://t.co/taRxMTeZsM
7:15am November 14th 2016 via Hootsuite
New statin guidelines: Everyone 40 and older should be considered for the drug therapy - The Washington Post https://t.co/GQjaWa1N0N
6:56am November 14th 2016 via Hootsuite
The African-made genetic chip could revolutionize medicine made for Africans — Quartz https://t.co/USbh0w2VeG
8:41pm November 13th 2016 via Hootsuite
First home brain implant lets ‘locked-in’ woman communicate | New Scientist https://t.co/sfKzEOhVdk
11:55am November 13th 2016 via Hootsuite
Thank you @archerdxinc for a great #AMP2016 memento https://t.co/AyPwlMS4j6
12:15pm November 12th 2016 via Hootsuite
Linderman: 3% of lung ca, has exon 14 skip, crizotinib skipping. Sequencing of introns - where the pathology lies... #AMP2016
11:24am November 12th 2016 via Twitter Web Client
Linderman: MET in NSCLC, a complicated story can co-exist w/other oncogene muts. MET-inh not effective. NGS for exon 14 splicing #AMP2016
11:23am November 12th 2016 via Twitter Web Client
Linderman: RET in NSCLC, different partners in lung ca - KIF5B, CDD6, NCOA4. Hard via FISH or IHC. #AMP2016
11:22am November 12th 2016 via Twitter Web Client
Linderman: Many more inh in dev; not enough evidence for routine ERBB2 testing. #AMP2016
11:21am November 12th 2016 via Twitter Web Client
Linderman: For ERBB2 (HER2) in NSCLC, same gene, completely different mechanism. Lung: exon 20, activation, same tests not useful #AMP2016
Linderman: #AMP2016 For BRAF and lung ca - recent paper, PhII data, 33% resp to V600E dabrafenib https://t.co/i2uWcjywgO
11:20am November 12th 2016 via Twitter Web Client
Linderman: Single-gene KRAS still useful as 30% of adenocarcinomas. 'It is what we think is useful for std of care' #AMP2016
11:19am November 12th 2016 via Twitter Web Client
Linderman: KRAS in NSCLC, no effective direct inhibitor; recent reports to target MEK-inh. Useful to 'rule-out' other muts #AMP2016
11:18am November 12th 2016 via Twitter Web Client
Linderman: Other genes: BRAF, ERBB2, KRAS, MET. not mutually exclusive. Limited evid for clinical utility. Can be part of panel #AMP2016
11:17am November 12th 2016 via Twitter Web Client
Linderman: RNA methods 'not established well', nor DNA methods, but expect progress in this area #AMP2016
11:16am November 12th 2016 via Twitter Web Client
Linderman: '14 NEJM https://t.co/S8f57syxUM No designated Companion Dx (CDx), 'you are safe w/FISH'. #AMP2016
11:15am November 12th 2016 via Twitter Web Client
Linderman: ROS1 pos, Rx crizotinib, good response, relapse after 2+ y, new Rx, still in remission. ROS1+ resp to crizotinib #AMP2016
11:13am November 12th 2016 via Twitter Web Client
Linderman: Other genes to test? ROS1, RET, BRAF... Case study ROS1, 73yo M, adeno IIIA, EGFR, KRAS ALK neg. Plat. Rx, liver met #AMP2016
11:12am November 12th 2016 via Twitter Web Client
Linderman: NGS methods unproven for cfDNA, PCR methods appropriate (digital or real-time). No recommendation re:reporting #AMP2016
11:10am November 12th 2016 via Twitter Web Client
Linderman: Sample proc is critical - Sreck or EDTA if processed in hours. Different centrifugation level (no brakes) #AMP2016
Linderman: More work to be done. Acquired resistance - sensitivity is high 60-80%, specificity high. Treat if plasma-pos #AMP2016
11:09am November 12th 2016 via Twitter Web Client
